This year, FERO will contribute €200,000, with which it will seek to provide structural and sustained support for the Molecular Diagnostics Programme1
The centre becomes the first in Spain to use blood biomarker p-tau217, which offers a more accurate and less invasive diagnosis and marks a paradigm1
The Minister and the Director of CERCA met with the management of the centre and visited IDIBAPS' facilities.
The BBVA Foundation – Hospital Clínic de Barcelona Advanced Research Contracts are aimed at specialists in the Health Sciences, with experience in re1
Researchers at the Hospital Clínic-IDIBAPS are leading a study that shows that participating in professional football as an occupation is a factor th1
Gene therapy applied to the treatment of neurodegenerative diseases is a promising field of study, and consists of modifying a patient's genes to slo1
A study by the hospital Clínic Barcelona-IDIBAPS, published in the journal Neurology, confirms the usefulness of a blood-based biomarker to diagnose1
Dr. Josep Baselga, an internationally renowned medical oncologist, died of this degenerative disease on 21 March 2021. The meeting was attended1
